GHK-Cu

In 1988, Maquart and colleagues, working with Pickart, reported direct evidence of what the peptide does. They added GHK-Cu to cultures of fibroblasts, the cells that make collagen. Collagen production rose at vanishingly small concentrations, and it did so without any change in the number of cells. The peptide was changing what the cells did, rather than simply making more of them.

Five years later Maquart’s team took it into living tissue. They implanted small mesh chambers under the skin of rats, a standard model of a healing wound, and injected GHK-Cu or saline into them. The chambers that got GHK-Cu filled with more collagen, more glycosaminoglycans (the water-holding gel between fibers) and more total protein, in proportion to the amount given. Collagen rose twice as much as other proteins, and a look-alike control tripeptide did nothing.

Reviews add a longer list: GHK-Cu draws macrophages, mast cells and capillary cells to an injury, encourages new blood vessels and nerve fibers, and raises decorin, a small protein that keeps collagen fibers neatly spaced. One detail is easy to miss and matters most. GHK stimulates both the synthesis and the breakdown of collagen, and it adjusts both the enzymes that dissolve old matrix and their inhibitors. That is the profile of a remodeling signal. Good repair means clearing scar and laying down organized tissue, and GHK appears to work on both sides of that ledger.⁷⁸⁶¹

In that 1988 paper, Maquart’s team pointed out that the exact sequence glycine, histidine, lysine appears inside the alpha-2 chain of type I collagen, the most abundant structural protein in your skin. Collagen, in other words, carries copies of GHK inside its own fibers.

Their proposal was elegant. When tissue is injured, enzymes called proteases chew through damaged collagen to clear the debris. If that chewing frees GHK, the act of breaking the scaffold would release the very signal that tells fibroblasts to rebuild it. Think of a building whose damaged walls contain sealed envelopes with the repair plans inside; the demolition crew opens them simply by doing its job.

This is a hypothesis. Nobody has tracked GHK being released from collagen in a human wound in real time. But it explains several things at once: why the peptide works at such tiny concentrations, why it acts on both building and clearing, and why a fall in circulating GHK with age might matter. Whether ageing also slows local release from collagen, or whether that release matters much for human wound repair, these studies do not establish.

It also reframes what a cream or injection could and could not do. Adding GHK-Cu from outside is meant to supply the message, though no study cited here shows a cream or injection reaching the right cells in people in a way that improves repair. Either way it cannot supply the protein, vitamin C, blood flow and freedom from UV damage that fibroblasts need to act on any message.⁷¹

The animal wound studies cited here report benefits across several models. Reviews describe faster healing of skin, hair follicles, gut lining and bone, and whole-body healing effects in rats, mice and pigs. A 2003 University of Florida study gives a clear picture. Researchers cut small wounds into a strip of rat skin with deliberately poor blood supply, the kind of setting where real chronic wounds stall.

By day 13, wounds treated with a GHK-Cu gel had shrunk by 64.5%, compared with 45.6% for the gel base alone and 28.2% for untreated wounds. The treated wounds also held lower levels of TNF-alpha, a key inflammatory signal, and of two matrix-dissolving enzymes, MMP-2 and MMP-9, that are often overactive in wounds that refuse to close.

People have been tested too, and the results split. In a 1994 multicenter, randomized, evaluator-blinded trial in diabetic foot ulcers, a GHK-Cu gel on top of careful standard care produced a median closure of 98.5% of plantar ulcer area, against 60.8% with the inactive gel. Larger plantar ulcers benefited most: a median 89.2% closure against a slight worsening with vehicle. Among plantar ulcers treated right after the wound was cleaned, infections ran 7% with GHK-Cu against 34% with vehicle.

Two years earlier, a randomized trial completed by 86 evaluable people with venous leg ulcers had compared a copper tripeptide cream with silver sulfadiazine and with placebo. The silver cream shrank ulcers; the copper tripeptide cream did no better than placebo. Different wounds, different formulations, opposite results. The fair summary of the studies cited here: one encouraging GHK-Cu trial in diabetic plantar ulcers, one venous ulcer trial in which a copper tripeptide cream (its exact sequence not given in the abstract) did nothing, and nothing large or modern to settle the question.¹⁹¹⁰¹¹

Most people meet GHK-Cu in a serum bottle. Reviews from Pickart’s group report that in cosmetic products it tightens loose skin, improves elasticity, density and firmness, softens fine lines and wrinkles, reduces photodamage and uneven pigment, and increases the growth of keratinocytes, the cells of the outer skin. A 2008 review describes controlled studies on aged skin with these results.

A randomized study with blinded outcome assessment is more sobering. In a 2006 randomized trial, people who had laser resurfacing around the mouth used aftercare products with or without GHK-Cu. Blinded evaluators and computer analysis found no difference in how fast redness faded, and no difference in wrinkles or overall skin quality at 12 weeks. Both groups improved a lot, as people do after laser treatment.

What did differ was satisfaction. The GHK-Cu group rated their overall skin quality as more improved on a validated questionnaire. Only 13 people completed the study, so it neither proves nor disproves a cosmetic effect. It does show that how skin feels to its owner and how it measures under a camera can diverge, which is worth remembering when reading testimonials.¹⁶⁴

Hair claims for copper peptides are everywhere, so it helps to know what sits underneath them. Reviews list hair follicle healing, larger follicle size and better hair transplant success among GHK-Cu’s effects. Those statements come largely from the same research group.

The study most often quoted as independent evidence was published in 2007 by a team in Seoul. It tested AHK-Cu, a close cousin in which alanine replaces glycine. AHK-Cu lengthened human hair follicles kept alive in a dish and boosted the growth of dermal papilla cells, the specialized cells at the base of the follicle that drive hair growth, and shifted their markers of programmed cell death in a protective direction.

That is useful biology, and it suggests the copper-peptide family can act on follicles. It is still a different molecule, in follicles outside a body. None of the sources cited here includes a controlled human trial of GHK-Cu alone for hair loss, so anyone choosing it for hair is making a bet on mechanism, not on measured outcomes.⁶¹¹²

The boldest claim about GHK is that it can raise or lower the activity of at least 4,000 human genes, nudging cells toward a more youthful pattern. That figure comes from Pickart’s reviews, which mined public gene-expression databases. Changing gene activity in cultured cells is a long way from changing health, and big numbers in these databases are easy to generate.

The more convincing gene evidence came from a separate research team studying COPD. In 2012, researchers at Boston University, the University of British Columbia and the University of Groningen profiled 64 tissue samples, eight regions from each of eight lungs removed from smokers with COPD. They found 127 genes whose activity tracked how badly each region was destroyed by emphysema. Repair genes, including the TGF-beta pathway, faded as damage grew.

They then searched the Connectivity Map, a library of how thousands of compounds shift gene activity, for anything that pushed the emphysema pattern the other way. GHK came up. In the lab, it switched on repair-pattern genes in human fibroblasts, organized the cells’ internal skeleton, and restored the ability of fibroblasts from COPD lungs to contract and remodel collagen. A computer search for lung repair landed on the same repair theme Pickart had described for skin.

None of this has been tested as a lung treatment in people. But it is independent support for the idea that GHK is a genuine tissue-remodeling signal, and it came from an unexpected direction.²¹¹³

On the skin, GHK-Cu is widely used in cosmetic products. In the diabetic ulcer trial, infections were actually less common with the GHK-Cu gel than with vehicle. That record covers topical use only.

Injection is a different matter. FDA’s compounding safety page lists GHK-Cu for injectable routes among substances that may present significant safety risks. It points to immunogenicity, an immune reaction that can happen when peptides clump together or carry manufacturing impurities, and to limited human safety data. The human trials cited here all used topical products, so they say nothing about the efficacy or long-term safety of injections.

The cancer question deserves a straight answer. The very first paper on GHK reported that it stimulated growth in liver cancer cells in culture. Later reviews from Pickart’s group describe the reverse in other cancer cells, with genes that suppress cancer growth switched on. Mixed lab signals and no long-term human data mean anyone with a cancer history should talk with a clinician first.

Because GHK-Cu delivers copper, people with disorders of copper handling, such as Wilson disease, should avoid it unless a specialist says otherwise. Pregnancy, breastfeeding and known copper allergy belong on the same ask-first list.¹⁰¹⁴⁵²

Skin is a readout of whole-body chemistry, so the useful labs are the ones that track what ages collagen. HbA1c, your average blood sugar over about three months, matters because glucose sticks to collagen fibers and cross-links them, a process called glycation, which stiffens skin. No study here tests how blood sugar changes a person’s response to GHK-Cu, but it is useful context for skin either way.

hs-CRP, high-sensitivity C-reactive protein, measures low-grade inflammation anywhere in the body. It is nonspecific and no study validates it for choosing or tracking GHK-Cu, but it is general baseline context a clinician can read alongside your history. Zinc is worth knowing as general context because zinc and copper compete for absorption in the gut; no study here shows that topical or injected GHK-Cu lowers zinc.

No lab monitoring protocol for injected GHK-Cu exists in these studies, and normal liver enzymes would not prove an injection safe; a clinician may still want a general baseline such as ALT. At Vitals Vault, peptide care starts with a blood panel at Quest Diagnostics, a licensed clinician reviews the results and your history, and the same markers are retested afterward.³

GHK-Cu is sold legally as a cosmetic ingredient in creams and serums. It is not an FDA-approved drug for any condition, so no regulator has reviewed evidence that it works for any medical use.

For injections, FDA’s April 2026 compounding safety page lists GHK-Cu among bulk substances that may present significant safety risks, citing immunogenicity and limited human data. That places injectable GHK-Cu in a more cautious category than the topical products most people use.¹⁴¹

GHK-Cu is a real repair signal with a genuinely clever biology: a copper courier that fades with age and whose sequence is built into collagen itself. In the cell and animal studies cited here it helps tissue rebuild. In people, the evidence is a handful of small topical trials that point in different directions, and none of them tested the injectable form.

If your goal is better skin, the most useful question is not which copper peptide to buy. It is what is breaking your collagen down faster than you rebuild it: sun, blood sugar, inflammation or simply a thin diet. Answer that first with a clinician, using a blood panel as general context, and you will know which levers to pull before reaching for a repair signal.¹⁴¹⁰